What is personalized medicine, and how can it help acute myeloid leukemia (AML) patients? Find out during this live AML webinar on Monday, December 11 at 2:30 PM ET, 11:30 AM PT, 1:30 PM CT, in partnership with The Leukemia & Lymphoma Society (LLS). We’ll be broadcasting from the annual American Society of Hematology (ASH) meeting, so register now to watch live or get access to the replay afterwards.
During the webinar, you’ll hear a panel of experts give an overview of the AML news coming out of ASH, personalized medicine options available and more. There will also be a question-and-answer session, so send in your questions now to email@example.com.
Join us to learn about:
- Approved and promising personalized medicine approaches for AML patients
- How to access a clinical trial that’s right for you
- The current limitations of personalized medicine
Once you register, you will receive a confirmation email with details for joining the program at the scheduled time.
This is a Patient Empowerment Network program produced by Patient Power, in partnership with The Leukemia & Lymphoma Society (LLS). We thank Astellas, Celgene Corporation, Novartis, Pfizer and Seattle Genetics for their support.